Caroline Irene Piatek, MD

Title(s)Clinical Associate Professor of Medicine (Clinician Educator)
SchoolKeck School of Medicine of Usc
Address1441 Eastlake Ave.
Health Sciences Campus
Los Angeles CA 90033
vCardDownload vCard
    Other Positions
    Title(s)Hematology/Oncology Fellowship Program Director

    Title(s)Service Chief for Hematology at LAC+USC

    Collapse Biography 
    Collapse Awards and Honors
    USC2012  - 2013Medical Oncology Fellow Research Award
    American Society of Clinical Oncology2014Conquer Cancer Foundation Merit Award
    Keck School of Medicine of USC2014  - 2015Hematology Chief Fellow

    Collapse Overview 
    Collapse Overview
    Dr. Carolne Piatek is an Associate Professor in the Jane Anne Nohl Division of Hematology at the Keck School of Medicine of USC. She is currently the fellowship director for the USC/LAC+USC Medical Hematology Fellowship Program. Dr. Piatek’s clinical focus is in non-malignant hematology. Her research interests include immune thrombocytopenia, warm autoimmune hemolytic anemia, cancer-associated thrombosis and paroxysmal nocturnal hemoglobinuria.

    After earning her medical degree from Creighton University School of Medicine, Dr. Piatek completed internal medicine residency and hematology/medical oncology fellowship at the University of Southern California.

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Addition of danicopan to ravulizumab or eculizumab in patients with paroxysmal nocturnal haemoglobinuria and clinically significant extravascular haemolysis (ALPHA): a double-blind, randomised, phase 3 trial. Lancet Haematol. 2023 Dec; 10(12):e955-e965. Lee JW, Griffin M, Kim JS, Lee Lee LW, Piatek C, Nishimura JI, Carrillo Infante C, Jain D, Liu P, Filippov G, Sicre de Fontbrune F, Risitano A, Kulasekararaj AG, ALXN2040-PNH-301 Investigators. PMID: 38030318.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCTClinical Trials
    2. Fostamatinib for warm antibody autoimmune hemolytic anemia: Phase 3, randomized, double-blind, placebo-controlled, global study (FORWARD). Am J Hematol. 2024 Jan; 99(1):79-87. Kuter DJ, Piatek C, Röth A, Siddiqui A, Numerof RP, Dummer W, FORWARD study group. PMID: 37929318.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCTClinical Trials
    3. Phase 3 Study of Subcutaneous Versus Intravenous Ravulizumab in Eculizumab-Experienced Adult Patients with PNH: Primary Analysis and 1-Year Follow-Up. Adv Ther. 2023 Jan; 40(1):211-232. Yenerel MN, Sicre de Fontbrune F, Piatek C, Sahin F, Füreder W, Ortiz S, Ogawa M, Ozol-Godfrey A, Sierra JR, Szer J. PMID: 36272026; PMCID: PMC9589670.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCTClinical Trials
    4. One-year outcomes from a phase 3 randomized trial of ravulizumab in adults with paroxysmal nocturnal hemoglobinuria who received prior eculizumab. Eur J Haematol. 2021 Mar; 106(3):389-397. Kulasekararaj AG, Hill A, Langemeijer S, Wells R, González Fernández FA, Gaya A, Ojeda Gutierrez E, Piatek CI, Mitchell L, Usuki K, Bosi A, Brodsky RA, Ogawa M, Yu J, Ortiz S, Röth A, Lee JW, Peffault de Latour R. PMID: 33301613; PMCID: PMC8246907.
      View in: PubMed   Mentions: 20     Fields:    Translation:HumansCTClinical Trials
    5. Patient preferences and quality of life implications of ravulizumab (every 8 weeks) and eculizumab (every 2 weeks) for the treatment of paroxysmal nocturnal hemoglobinuria. PLoS One. 2020; 15(9):e0237497. Peipert JD, Kulasekararaj AG, Gaya A, Langemeijer SMC, Yount S, Gonzalez-Fernandez FA, Ojeda Gutierrez E, Martens C, Sparling A, Webster KA, Cella D, Tomazos I, Ogawa M, Piatek CI, Wells R, Sicre de Fontbrune F, Röth A, Mitchell L, Hill A, Kaiser K. PMID: 32886668; PMCID: PMC7473546.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCTClinical Trials
    6. A Retrospective Study of the Combination of Rituximab, Cyclophosphamide and Dexamethasone for the Treatment of Relapsed/Refractory Warm Antibody Autoimmune Hemolytic Anemia. Acta Haematol. 2020; 143(3):244-249. Piatek CI, Bocian H, Algaze S, Weitz IC, O'Connell C, Liebman HA. PMID: 31665725.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    7. Case Report: Oxaliplatin-Induced Immune-Mediated Thrombocytopenia. Case Rep Oncol. 2018 Sep-Dec; 11(3):880-882. Pan E, Hsieh E, Piatek C. PMID: 30687065; PMCID: PMC6341312.
      View in: PubMed   Mentions: 3  
    8. Ravulizumab (ALXN1210) vs eculizumab in C5-inhibitor-experienced adult patients with PNH: the 302 study. Blood. 2019 02 07; 133(6):540-549. Kulasekararaj AG, Hill A, Rottinghaus ST, Langemeijer S, Wells R, Gonzalez-Fernandez FA, Gaya A, Lee JW, Gutierrez EO, Piatek CI, Szer J, Risitano A, Nakao S, Bachman E, Shafner L, Damokosh AI, Ortiz S, Röth A, Peffault de Latour R. PMID: 30510079; PMCID: PMC6368201.
      View in: PubMed   Mentions: 128     Fields:    Translation:HumansCTClinical Trials
    9. Autoimmune Myelofibrosis: Clinical Features, Course, and Outcome. Acta Haematol. 2017; 138(3):129-137. Piatek CI, Vergara-Lluri ME, Pullarkat V, Siddiqi IN, O'Connell C, Brynes RK, Feinstein DI. PMID: 28866671.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    10. Value of routine staging imaging studies for patients with stage III breast cancer. J Surg Oncol. 2016 Dec; 114(8):917-921. Piatek CI, Ji L, Kaur C, Russell CA, Tripathy D, Church T, Sposto R, Sener SF, Garcia AA. PMID: 27642105.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    11. OC-14 - Baseline D-dimer levels are predictive of recurrent venous thromboembolism (VTE) at 6 months in cancer patients with VTE treated with tinzaparin. Thromb Res. 2016 Apr; 140 Suppl 1:S174. Piatek CI, Tagawa ST, Wei-Tsai D, Hanna D, Weitz IC, O'Connell C, Rochanda L, Groshen S, Liebman HA. PMID: 27161687.
      View in: PubMed   Mentions: 1     Fields:    
    12. An Overview and Update of Chronic Myeloid Leukemia for Primary Care Physicians. Korean J Fam Med. 2015 Sep; 36(5):197-202. Granatowicz A, Piatek CI, Moschiano E, El-Hemaidi I, Armitage JD, Akhtari M. PMID: 26435808; PMCID: PMC4591383.
      View in: PubMed   Mentions: 22  
    13. Management of immune-mediated cytopenias in pregnancy. Autoimmun Rev. 2015 Sep; 14(9):806-11. Piatek CI, El-Hemaidi I, Feinstein DI, Liebman HA, Akhtari M. PMID: 25981747.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    14. Thrombocytopenia: optimizing approaches in cancer patients. Oncology (Williston Park). 2015 Apr; 29(4):297-8. Piatek C, Akhtari M. PMID: 25952494.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    15. Phase I clinical trial of temsirolimus and vinorelbine in advanced solid tumors. Cancer Chemother Pharmacol. 2014 Dec; 74(6):1227-34. Piatek CI, Raja GL, Ji L, Gitlitz BJ, Dorff TB, Quinn DI, Hu J, El-Khoueiry AB, Pham HQ, Roman L, Garcia AA. PMID: 25374407.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCTClinical Trials
    16. Autoimmune myelofibrosis: an update on morphologic features in 29 cases and review of the literature. Hum Pathol. 2014 Nov; 45(11):2183-91. Vergara-Lluri ME, Piatek CI, Pullarkat V, Siddiqi IN, O'Connell C, Feinstein DI, Brynes RK. PMID: 25282037.
      View in: PubMed   Mentions: 25     Fields:    Translation:Humans
    17. Unsuspected pulmonary embolism: impact on mortality among cancer patients. Curr Opin Pulm Med. 2012 Sep; 18(5):406-9. Piatek C, O'Connell C. PMID: 22759768.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    18. Treating venous thromboembolism in patients with cancer. Expert Rev Hematol. 2012 Apr; 5(2):201-9. Piatek C, O'Connell CL, Liebman HA. PMID: 22475288; PMCID: PMC4435973.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    19. Genetic screens for enhancers of brahma reveal functional interactions between the BRM chromatin-remodeling complex and the delta-notch signal transduction pathway in Drosophila. Genetics. 2005 Aug; 170(4):1761-74. Armstrong JA, Sperling AS, Deuring R, Manning L, Moseley SL, Papoulas O, Piatek CI, Doe CQ, Tamkun JW. PMID: 15944353; PMCID: PMC1449748.
      View in: PubMed   Mentions: 24     Fields:    Translation:AnimalsCells
    Caroline's Networks
    Concepts (104)
    Derived automatically from this person's publications.
    Co-Authors (15)
    People in Profiles who have published with this person.
    Similar People (60)
    People who share similar concepts with this person.
    Same Department
    Search Department